Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Phage Therapy: A Practical Approach -

Phage Therapy: A Practical Approach

Buch | Hardcover
XV, 385 Seiten
2019 | 1st ed. 2019
Springer International Publishing (Verlag)
978-3-030-26735-3 (ISBN)
CHF 209,70 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

This book gives a detailed yet clear insight into the current state of the art of the therapeutic application of bacteriophages in different conditions. The authors bring in their practical expertise within their respective fields of expertise and provide an excellent overview of the potential and actual use of phage therapy. Topics like economic feasibility compared to traditional antibiotics and also regulatory issues are discussed in far detail.

This new volume is therefore a valuable resource for individuals engaged in the medical application of novel phage therapies.

Prof.A.Górski, MD, PhD is head of the Bacteriophage Laboratory and Phage Therapy Center.Hismain interests are phage therapy and immunobiology of phage. In the 2000s he presented a hypothesis on protective action of endogenous phages which involves not only their antibacterial but also antiinflammatory and immunomodulatory action. Subsequently, he formulated a hypothesis on phage translocation from the gastrointestinal tract to other tissues where phages could mediate their effects. In the past few years he has published articles envisaging the potential role of phages in the treatment of autoimmune disorders, allergy and graft-versus-host disease ("phage repurposing")(A.Górski et al., Med Res Rev 2019 doi: 10.1002/med.21593). He was a co-editor of a book on phage therapy (see above).

Part I: Bacteriophages as antibacterialagents.- Chapter 1:Production of PhageTherapeutics and Formulations - InnovativeApproaches.- Chapter 2:Phagepharmacokinetics: relationship with administrationroute.- Chapter 3:BacterialResistance to Phage and itsImpact on Clinical Therapy.- Part II:  Bacteriophages and the immune system.- Chapter 4:Phageinteraction with the mammalianimmune system.- Chapter 5:Humoralimmuneresponse to phage-basedtherapeutics.- Part III:Use of bacteriophages to combat bacterial infections.- Chapter 6:How to achieve a goodphage therapy clinical trial?.- Chapter 7: Perspectives on the RenewedInterest in the United States.- Chapter 8:Phage Therapy in Orthopaedic Implant-associated Infections.- Chapter 9:The use of bacteriophages in animalhealth and food protection.- Chapter 10:Combiningbacteriophages with otherantibacterialagents to combatbacteria.- Chapter 11: Phage therapy of infectious biofilms: Challenges and strategies.- Part IV:Phage therapy - regulatory and ethical aspects.- Chapter 12:Regulatory Considerations for Bacteriophage Therapy Products.- Chapter 13:Developing phagesintomedicines for Europe.- Chapter 14: Phagetherapy in Europe: Regulatory and intellectualpropertyprotectionissues.- Chapter 15:Ethics of phagetherapy.- Part V: Bacteriophage-derived antibacterial agents.- Chapter 16: NovelAlternative to Antibiotics.


Erscheinungsdatum
Zusatzinfo XV, 385 p. 26 illus., 24 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 763 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Mikrobiologie / Infektologie / Reisemedizin
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Genetik / Molekularbiologie
Naturwissenschaften Biologie Mikrobiologie / Immunologie
Schlagworte antibiotic resistance • human infection • MDR multiple drug resistance • phage typing • viruses infecting bacteria
ISBN-10 3-030-26735-0 / 3030267350
ISBN-13 978-3-030-26735-3 / 9783030267353
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
und Erste Hilfe an Bord

von Jürgen Graf; Jochen Hinkelbein

Buch | Softcover (2024)
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
CHF 55,90